Immune System News and Research

RSS

Study reveals a testable hypothesis to explain the initiation of autoimmunity in T1D patients

Type 1 diabetes (T1D) is an autoimmune disease in which the pancreas makes little or no insulin. The details on the events that occur during autoimmune destruction of the pancreatic beta-cells have been studied extensively yet the mystery of what causes autoimmunity is unknown.

23 Sep 2022

Shattered dreams and bills in the millions: Losing a baby in America

The day after his 8-month-old baby died, Kingsley Raspe opened the mail and found he had been sent to collections for her care.

23 Sep 2022

Study paves the way for new therapies, vaccines that lead to stronger immunity against Covid-19

Why do some people become seriously ill with Covid-19, while others have no symptoms at all? The answer may lie in the proteins our immune system has previously been exposed to.

23 Sep 2022

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

As part of Sepsis Awareness Month, celebrated annually in September, News Medical Speaks to Dr. Ron Daniels, founder, and chief executive of the UK Sepsis Trust, about the significance of sepsis awareness, support for patients, and improving outcomes for sepsis survivors.

23 Sep 2022

Vaccine boosters and breakthrough infections provide substantial immunity against COVID-19

Vaccine boosters and breakthrough infections following vaccination both provide a substantial and potentially pandemic-breaking immunity against COVID-19, according to new laboratory research from Oregon Health & Science University.

22 Sep 2022

AI-guided tools pinpoint immune cell driver and protective genetic factor for esophageal cancer

Esophageal adenocarcinoma (EAC) is a type of cancer affecting the mucus-secreting glands of the lower esophagus - the tube connecting the throat to the stomach.

22 Sep 2022

Dietary sugar may disrupt gut microbiota and induce metabolic complications

A new study demonstrates that dietary sugar increases the risk of metabolic syndrome by disrupting gut microbiota and suppressing protective T helper 17 (Th17) cells.

22 Sep 2022

Scientists uncover key details of an immune-cell process that underlies excessive inflammation

A team led by Scripps Research scientists has uncovered key details of an immune-cell process that frequently underlies excessive inflammation in the body.

22 Sep 2022

Most people infected with SARS-CoV2 recover within 12 months, study finds

A McMaster University-led study has found that most people infected with the SARS-CoV2 virus recover within 12 months, irrespective of the severity.

22 Sep 2022

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Health~Holland has awarded close to € 800,000 to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc. (USA) and MicroViable Therapeutics (Spain) to unravel how the intestinal microbiota can be exploited to boost cancer immunotherapy and limit therapy side-effects.

21 Sep 2022

Prophylactic administration of SARS-CoV-2 specific immunoglobulin Y generated in chicken eggs displays protective effects in infected mice

A new study characterized and tested the antibody activity of SARS-CoV-2-specific immunoglobulin Y (IgY) derived from the eggs laid by chickens immunized with recombinant SARS-CoV-2 receptor binding domain (RBD) protein.

21 Sep 2022

Formula may be right for infants, but experts warn that toddlers don’t need it

Formulas for toddlers are a burgeoning business in the United States: Sales of the drinks more than doubled in recent years as companies convinced parents that their little ones needed the liquid boost.

21 Sep 2022

Discovery of novel pathway offers a potential solution for preventing cancer chemo-resistance

Researchers have uncovered a novel pathway that explains how cancer cells become resistant to chemotherapies, which in turn offers a potential solution for preventing chemo-resistance.

20 Sep 2022

Tumors generate unique, temporary cell-in-cell structures to evade immunotherapy

Scientists have shown how tumour cells evade immunotherapy by generating unique, temporary cell-in-cell structures, where the inner cells remain in tact and can return to single tumour cells.

20 Sep 2022

UTHSC-led researchers receive $5.2 million to study obesity-mediated cancer risk

The National Cancer Institute has awarded more than $5.2 million to a team lead by researchers from the University of Tennessee Health Science Center for a study that will fill critical gaps in knowledge around obesity-mediated cancer risk.

20 Sep 2022

Humanized zebrafish could aid in the search for MS drugs

The zebrafish should be known to many aquarium enthusiasts mainly because of its striking pigmentation. However, the characteristic black-blue stripes, to which the animal owes its name, only form over time.

20 Sep 2022

BU investigator wins highly competitive awards to study the role of proteases in regulation of cellular defenses

Mohsan Saeed, PhD, assistant professor of biochemistry at Boston University School of Medicine (BUSM), has received a five-year, $2 million R35 grant from the National Institute of General Medical Sciences, as well as a five-year, $2.5 million R01 grant from the National Institute of Allergy and Infectious Diseases.

20 Sep 2022

Link between type 2 diabetes and UTIs explained

Lower immunity and recurring infections are common in type 1 and type 2 diabetes. Researchers at Karolinska Institutet in Sweden now show that the immune system of people with diabetes has lower levels of the antimicrobial peptide psoriasin, which compromises the urinary bladder's cell barrier, increasing the risk of urinary tract infection.

20 Sep 2022

Clearing pollution helps clear the fog of aging — and may cut the risk of dementia

During the past decade, a growing body of research has shown that air pollution harms older adults' brains, contributing to cognitive decline and dementia. What hasn't been clear is whether improving air quality would benefit brain health.

20 Sep 2022

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Early intervention with rituximab, a drug used in the treatment of rheumatoid arthritis (RA), can reduce the risk of deterioration in myasthenia gravis, an autoimmune disease that causes loss of muscle control.

19 Sep 2022

Immune System News and Research

Study reveals a testable hypothesis to explain the initiation of autoimmunity in T1D patients

Shattered dreams and bills in the millions: Losing a baby in America

Study paves the way for new therapies, vaccines that lead to stronger immunity against Covid-19

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

Vaccine boosters and breakthrough infections provide substantial immunity against COVID-19

AI-guided tools pinpoint immune cell driver and protective genetic factor for esophageal cancer

Dietary sugar may disrupt gut microbiota and induce metabolic complications

Scientists uncover key details of an immune-cell process that underlies excessive inflammation

Most people infected with SARS-CoV2 recover within 12 months, study finds

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Prophylactic administration of SARS-CoV-2 specific immunoglobulin Y generated in chicken eggs displays protective effects in infected mice

Formula may be right for infants, but experts warn that toddlers don’t need it

Discovery of novel pathway offers a potential solution for preventing cancer chemo-resistance

Tumors generate unique, temporary cell-in-cell structures to evade immunotherapy

UTHSC-led researchers receive $5.2 million to study obesity-mediated cancer risk

Humanized zebrafish could aid in the search for MS drugs

BU investigator wins highly competitive awards to study the role of proteases in regulation of cellular defenses

Link between type 2 diabetes and UTIs explained

Clearing pollution helps clear the fog of aging — and may cut the risk of dementia

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Immunology eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News